In particular, dysregulation of Akr1d1 has been associated with human NAFLD68, and upregulation of Yap1 (paralogue of Wwtr1) in human and murine NASH liver70. Here, AKR1D1 is linked to metabolic dysfunction-associated steatohepatitis.